More
    HomeAsian HealthInsurers face repricing crunch as Asia’s chronic disease burden mounts

    Insurers face repricing crunch as Asia’s chronic disease burden mounts

    Published on

    The morbidity deterioration behind the claims

    New research from AIA Group, published July 13, 2026, puts a specific face on the deteriorating morbidity picture. The report documents declining healthy life expectancy – years lived in good health beyond age 60 – across several key markets between 2019 and 2021: from 13.3 to 11.4 years in the Philippines, 13.8 to 11.9 years in Indonesia, 13.6 to 11.5 years in India, and 14.9 to 13.8 years in Malaysia. The AIA research argues that this deterioration is partly driven by non-biological factors – declining community participation, social isolation, and loss of purpose in later life – that traditional morbidity models do not capture. Stuart A. Spencer, AIA’s group chief marketing officer, framed it as an industry-wide challenge: “Life is more nuanced than the traditional risk factors insurers have employed. We need to extend our imagination and our curiosity to better understand seniors and appreciate how other factors contribute to improved mortality, morbidity, and longevity.” Whether or not insurers move to incorporate psychosocial variables into underwriting – no Asian regulator has yet required it – the underlying deterioration in healthspan is already flowing through to claims.

    Source link

    Latest articles

    Asia's tech exports cushioned from tariff blow

    KUALA LUMPUR: Asia's technology exporters are expected to weather the latest round of the...

    Insight: China’s memory chip makers ride AI boom to new power

    For months, Chinese chip manufacturer ChangXin Memory Technologies (CXMT) had been hiking prices on...

    Asian Stocks Set to Fall as Oil Surges Past $100: Markets Wrap

    Stocks in Asia were poised for declines after a sharp Wall Street selloff, while...

    More like this

    S. Korea, Japan lead Asia in life expectancy at 84.1 years: study

    COVID-19 cut life expectancy by 0.33 years in Southeast Asia and 0.28 years in...

    Malaysia healthcare kept at Market Weight as earnings outpace revenue

    Hospital revenue growth is projected at 12.4% in 2026.Malaysia's healthcare sector maintained a Market...